Steven Cohen’s DexCom DXCM Stock Holding History

Steven Cohen’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Sell	7,400 -46,400	-86%	-$3.09M	﹤0.01%	3173
2026 Q1	$3.38M	Sell	53,800 -162,900	-75%	-$11.3M	﹤0.01%	1957
2025 Q4	$14.4M	Buy	216,700 +128,900	+147%	+$8.33M	0.02%	1115
2025 Q3	$5.91M	Buy	87,800 +69,900	+391%	+$5.53M	0.01%	1002
2025 Q2	$1.56M	Buy	17,900 +5,700	+47%	+$447K	﹤0.01%	1407
2025 Q1	$833K	Hold	12,200	–	–	﹤0.01%	1491
2024 Q4	$949K	Sell	12,200 -87,800	-88%	-$6.5M	﹤0.01%	1470
2024 Q3	$6.7M	Buy	+100,000	New	+$8.21M	0.02%	785
2024 Q2	–	Sell	-80,000	Closed	-$11.1M	–	1992
2024 Q1	$11.1M	Buy	80,000 +68,000	+567%	+$8.55M	0.03%	679
2023 Q4	$1.49M	Buy	+12,000	New	+$1.23M	﹤0.01%	1292
2023 Q3	–	Sell	-10,000	Closed	-$1.29M	–	2556
2023 Q2	$1.29M	Buy	+10,000	New	+$1.21M	﹤0.01%	1100
2019 Q2	–	Sell	-200,000	Closed	-$5.96M	–	1382
2019 Q1	$5.96M	Buy	+200,000	New	+$7.03M	0.03%	524
2018 Q1	–	Sell	-340,000	Closed	-$4.88M	–	980
2017 Q4	$4.88M	Buy	+340,000	New	+$4.42M	0.02%	597
2017 Q1	–	Sell	-800,000	Closed	-$11.9M	–	840
2016 Q4	$11.9M	Buy	+800,000	New	+$14.2M	0.08%	276

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Steven Cohen's DXCM Position: Q2 2026 in Review

Steven Cohen increased its DexCom (DXCM) stake by 9.9% in Q2 2026, buying an estimated $1.7M and bringing the position to 282,840 shares worth $19M. The position accounts for 0.02% of the portfolio, ranked #919.

Steven Cohen first reported a position in DXCM in Q4 2015 and has held it in 34 quarters since. The position peaked at $181M in Q1 2023. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Steven Cohen held 282,840 shares of DexCom worth $19M as of Q2 2026.
Steven Cohen bought 25,542 DexCom shares in Q2 2026, an estimated $1.7M.
DexCom made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #919 holding.
Steven Cohen first reported a position in DexCom in Q4 2015 and has held it in 34 quarters since.
Steven Cohen's DexCom position peaked at $181M in Q1 2023.
966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.